Location History:
- Arlington, MA (US) (1997)
- Acton, MA (US) (1999)
Company Filing History:
Years Active: 1997-1999
Title: **Innovative Contributions of Michael Alan Boss in Genetic Research**
Introduction
Michael Alan Boss, an esteemed inventor based in Arlington, MA, has made significant strides in the field of genetic research. With a total of two patents to his name, Boss's work focuses on mutations related to X-linked Charcot-Marie-Tooth (CMT) disease, contributing to advancements in the diagnosis and understanding of this condition.
Latest Patents
Boss's latest patents reveal crucial insights into specific mutations in the connexin-32 gene associated with X-linked Charcot-Marie-Tooth disease. These inventions disclose methods of diagnosing the disease through techniques such as hybridization analysis, including Southern or Northern analysis, and direct mutation analysis. Notably, his patents include mutant connexin-32 nucleic acid probes with identified mutations in codons such as 13, 16, 20, and numerous others, as well as methods for detecting these mutations. Additionally, isolated mutant connexin-32 proteins and specific antibodies for these proteins are also outlined in his patents, showcasing the depth and applicability of his research.
Career Highlights
Michael Alan Boss serves as a key figure at Athena Diagnostics, Inc., where his expertise in genetics complements the company's mission to innovate solutions for genetic testing. His patents underscore his commitment to advancing the understanding of genetic disorders, particularly CMT disease, which significantly impacts a considerable number of individuals.
Collaborations
During his career, Boss has collaborated with notable coworkers, including Uma Ananth and Kimberley Ottaway. These partnerships create a collaborative environment conducive to innovation and ensure the ongoing advancement of research initiatives within the company.
Conclusion
Michael Alan Boss exemplifies the pivotal role inventors play in translating scientific discoveries into practical applications. His contributions to understanding X-linked Charcot-Marie-Tooth disease through innovative methodologies and patents pave the way for improved diagnostics and potential treatments, ultimately benefiting those affected by this genetic disorder.